The Asia Pacific Neuromonitoring Devices Market is expected to witness market growth of 7.9% CAGR during the forecast period (2022-2028).
Sharp probing and direct observation to ensure a safe path across the working tunnel to the disc space, EMG stimulation is used. The posterior edge of the discectomy is then created by inserting a shim down the posterior blade and tapping it into the disc space under fluoroscopic and visual supervision. After seeing the ALL and retracting any remaining muscle tissue anteriorly, a tiny retractor is placed between the craniocaudal blades. It is then gently moved along the anterior boundary of the ALL, which is verified by fluoroscopic imaging.
Entirety, as well as the anterior visceral and vascular structures, are protected by this tool, which is fastened to the index retractor and acts as the anterior border of the safe operation field. The segmental arteries, which are direct offshoots of the aorta and can cause considerable hemorrhage if torn, as well as the psoas muscle and neurological tissues, are all at risk of injury from severe retractor separation and toeing of the blades.
A sizable number of developments are now taking place in this region. Several developing nations, including China and India, are located in this region. To provide their residents with better care, governments in these nations are increasing the amount of money they invest in building out their healthcare infrastructure. Additionally, the region's population's per capita disposable income is rising, which enables them to buy a range of pricey and incredibly evolved treatment modalities.
Since the prevalence of neurological diseases is on the rise in Asia Pacific, as is the advancement of neuromonitoring technology, the region's neuromodulation market is growing. Among the most prevalent neurological disorders, depression affects people of all ages. The majority of people suffering from depression in developing countries is poor and stressed financially because of various socioeconomic factors. Dystonia, Parkinson's disease, and obsessive-compulsive disorder are a few additional neurological conditions that are frequently observed in elderly adults.
The China market dominated the Asia Pacific Neuromonitoring Devices Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $652.4 million by 2028.The Japan market is poised to grow at a CAGR of 7.2% during (2022-2028). Additionally, The India market is expected to display a CAGR of 8.6% during (2022-2028).
Based on Product, the market is segmented into Doppler Ultrasound, EEG, Fetal/Neonatal Neuro-Monitoring Devices, Intracranial Pressure Monitoring, Cerebral Ox meter, Near Infrared Spectroscopy, Speckle Imaging, Micro Ultrasound, and Others. Based on End User, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Medtronic PLC, Nihon Kohden Corporation, Natus Medical Incorporated, Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.
By Product
Sharp probing and direct observation to ensure a safe path across the working tunnel to the disc space, EMG stimulation is used. The posterior edge of the discectomy is then created by inserting a shim down the posterior blade and tapping it into the disc space under fluoroscopic and visual supervision. After seeing the ALL and retracting any remaining muscle tissue anteriorly, a tiny retractor is placed between the craniocaudal blades. It is then gently moved along the anterior boundary of the ALL, which is verified by fluoroscopic imaging.
Entirety, as well as the anterior visceral and vascular structures, are protected by this tool, which is fastened to the index retractor and acts as the anterior border of the safe operation field. The segmental arteries, which are direct offshoots of the aorta and can cause considerable hemorrhage if torn, as well as the psoas muscle and neurological tissues, are all at risk of injury from severe retractor separation and toeing of the blades.
A sizable number of developments are now taking place in this region. Several developing nations, including China and India, are located in this region. To provide their residents with better care, governments in these nations are increasing the amount of money they invest in building out their healthcare infrastructure. Additionally, the region's population's per capita disposable income is rising, which enables them to buy a range of pricey and incredibly evolved treatment modalities.
Since the prevalence of neurological diseases is on the rise in Asia Pacific, as is the advancement of neuromonitoring technology, the region's neuromodulation market is growing. Among the most prevalent neurological disorders, depression affects people of all ages. The majority of people suffering from depression in developing countries is poor and stressed financially because of various socioeconomic factors. Dystonia, Parkinson's disease, and obsessive-compulsive disorder are a few additional neurological conditions that are frequently observed in elderly adults.
The China market dominated the Asia Pacific Neuromonitoring Devices Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $652.4 million by 2028.The Japan market is poised to grow at a CAGR of 7.2% during (2022-2028). Additionally, The India market is expected to display a CAGR of 8.6% during (2022-2028).
Based on Product, the market is segmented into Doppler Ultrasound, EEG, Fetal/Neonatal Neuro-Monitoring Devices, Intracranial Pressure Monitoring, Cerebral Ox meter, Near Infrared Spectroscopy, Speckle Imaging, Micro Ultrasound, and Others. Based on End User, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Medtronic PLC, Nihon Kohden Corporation, Natus Medical Incorporated, Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Doppler Ultrasound
- EEG
- Fetal/Neonatal Neuro-Monitoring Devices
- Intracranial Pressure Monitoring
- Cerebral Oximeter
- Near Infrared Spectroscopy
- Speckle Imaging
- Micro Ultrasound
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Koninklijke Philips N.V.
- Medtronic PLC
- Nihon Kohden Corporation
- Natus Medical Incorporated
- Nuvasive, Inc.
- Advanced Brain Monitoring, Inc.
- Intranerve Neuroscience Holdings, Llc
- Specialtycare
- RIMED Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Asia Pacific Neuromonitoring Devices Market by Product
Chapter 5. Asia Pacific Neuromonitoring Devices Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- General Electric (GE) Co. (GE Healthcare)
- Koninklijke Philips N.V.
- Medtronic PLC
- Nihon Kohden Corporation
- Natus Medical Incorporated
- Nuvasive, Inc.
- Advanced Brain Monitoring, Inc.
- Intranerve Neuroscience Holdings, Llc
- Specialtycare
- RIMED Ltd.
Methodology
LOADING...
